“Moderate” adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study

“Moderate” adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study

Abstract Background The association between chemotherapy-induced leukopenia (CIL) and survival for patients with early breast cancer (EBC) is not known. We investigated the relationship between different grades of CIL and survival in patients with EBC receiving adjuvant chemotherapy. Methods A total...

Full description

Bibliographic Details
Main Authors: Li Wang, Chang Jiang, Na Wang, Yan-Ling Wen, Si-Fen Wang, Cong Xue, Xi-Wen Bi, Zhong-Yu Yuan
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Cancer
Subjects:
Survival
Nomogram
Early Breast cancer
Chemotherapy-induced leukopenia
Online Access:https://doi.org/10.1186/s12885-023-11680-x

Similar Items

Similar Items